Effect of Shriphalkalka and niruh basti in irritable bowel syndrom (Grahani)

Comparative clinical Study of Shriphalshalatu Kalka & Erandamooladi Basti in Grahani with special reference to Irritable Bowel Syndrome - Irritable bowel syndrome

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081128

Enrollment

Registered

2025-02-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient having sign and symptoms of Grahani (as per classical text) Diagnosed and confirmed cases of Grahani (IBS) based on Subjective and Objective criteria Patient willing to enrolled in study Diagnostic Based Criteria - Classical sign and symptoms of Grahani. IBS as per for ROME IV criteria Manning criteria

Exclusion criteria

Exclusion criteria: Patients of either sex below 20 year and above 60 years will be excluded from the study. Patients with features of bleeding per rectum, mixed infection and evidence of malignancy. Patients with diabetes mellitus, poorly controlled hypertension, major cardiac problems.

Design outcomes

Primary

Measure	Time frame
Symptomatic improvement in subjective and objective criteria of IBS/ Grahani and assesmentental improvement in IBS Symptoms Severity ScoreTimepoint: Status of patients before and after treatment	—

Secondary

Measure	Time frame
Improvement in sign and symptoms of IBS IBS symptom severity scoreTimepoint: 45 days with follow up at 15 days	—

Countries

India

Contacts

Public ContactProf Sunanda Ramakrishna Pedhekar

Institute of medical science Bhu

drsrpedhekar@gmail.com09423241800

Outcome results